Master 2 Ingénierie pour la Santé et le Médicament
Université Joseph Fourier, Grenoble 14/10/2015
Alain Rodermann, Managing Partner
Raising VC Money
and More
1. VC$
2. FUNDRAI$ING
3. TERM$
4. WHERE
VC$
Georges Doriot
Someone,
somewhere,
is making a
product that
will make
your product
obsolete
The Recipe
What is the American Way of VC ?
20 companies in a fund
$1b companies candidates (unicorns)
2-4 blockbusters (x 10-50)
§ IPOs (big)
§ Trade sales (fast)
4-6 write-offs (x 0)
3-4 deals a year/ partner
VC	
  Business	
  Model
Lifetime 10y
+ Management fees 2%/y
- Hurdle rate 7%/y
- Losses 50%
=> average multiple for 0 carry = 5 X
Min Target Multiple = 10 X
VC returns
Source	
  avc.com
FUND
RAI$ING
The Powerpoint Presentation
Do VCs read business plans ?
How many scenarios ?
Bottom up monthly financial plan
Don’t underestimate salaries and staff size
Net income higher than 25% is suspect
Include international business if any
Can you make 10M€, 100M€ or more in sales ?
§ Money availability drives financial strategy
Conservative post money keeps options open
Try hiring a good fundraiser
VCs don’t sign NDAs
-­‐4
-­‐2
0
2
4
6
8
10
12
14
16
1 2 3 4 5 6 7 8 9
in
out
in	
  -­‐ out
cash	
  position
Phasing
21
0,1 0,7 2+
Break-­‐even
Should you accept more money than
you need ?
23
Geographical Breakdown
VC selection rate
1/300
European Market
European Market
European Market
Source	
  dowjones Venturewire ;	
  nb	
  of	
  deals	
  2Q2014
Biotech IPos
Biotech VC Market
33
Healthcare VC market
34
Healthcare : 30% of EU VC Investments
35
15 Top European Biotech VCs
1. Woodford
2. Sofinnova Partners
3. TVM
4. Abingworth
5. Wellington
6. HBM
7. Sunstone
8. Seventure
9. Dievini
10. Forbion
11. Truffle
12. Malin
13. Syncona
14. Edmond de
Rothschild
15. Ysios
36
TERM$
38
Guillaume	
  Bodinier,Contrat	
  de	
  mariage	
  en	
  Italie,	
  1831
Founder Dream
A bubble in the USA
Reality
Check
The VC
Arsenal
Is there a Valuation Magic Formula ?
R)(1
FV
R)(1
Ci
NPV n
1
0
i
+
+
+
= ∑
−n
Rodermann	
  
Magic
System
⎪⎩
⎪
⎨
⎧ ∏ −×+−≤
≤
+
≤
n
DiCpremoney
Cpremoney
C
010
0
0
0
)1(
FV
%50%15
Liquidation Preference Adjustments
1X	
  Double	
  dip,	
  participating 1X	
  Single	
  dip
invested shares % nominal premium
founders 100	
  000,00	
  € 100000 67% 1,00	
  € -­‐ €
VC 500	
  000,00	
  € 50000 33% 1,00	
  € 9,00	
  €
600	
  000,00	
  € 150000
Full Ratchet & Washout
Example
Ratchet
§ investor 2 wants to get 20% for 1M€
48
Series shareholder
Pre	
  
Money	
  
k€
k€
invested
€ per	
  
share
New	
  shares
total	
  
shares
Post	
  
money	
  k€
Options
seed Inception 0 100 1 100000 100000 100
A
Investor	
  	
  1
10000
3000
100
30000
130000 13000
ESOP 3000
B
investor	
  2
1300
1000
10,00
100000
500000 5000
0
ratchet	
  shares	
  
for	
  Investor	
  1
0 270000
Veto Rights
Reps and Warranties
How not to be fired in 6 months ?
Build a balanced board of brilliant
directors
Hire an experienced chairman
Pay an experiencedspecialized coach
Disclose problems as they arrive
Never Lie
Write minutes just after board meetings
Do what you promised to do
Becoming Global –
Should I stay or Should I go ?
WHERE
Operational efficiency
CLIENTS PARTNERSTALENTS TAX SUBSIDIES
SALES	
  &	
  MKT OPERATIONS R&D HEADQUARTERS
EU’s Four Freedoms
Free	
  movement	
  
Goods
Capital
Services
People	
  
within	
  EU's	
  
28	
  member	
  states
Transatlantic Trade and Investment
Partnership (in progress)
Access to Funding
VC
Corporate Tax Optimisation
SUBSTANCE=PEOPLE+DECISION
BRPS	
  :	
  OECD	
  Base	
  Erosion	
  and	
  Profit	
  Shifting	
  Project
Double	
  Irish	
  Dutch
Sandwich
Where will you live ? : Fame
Where will you live ? : Lifestyle
Where will you live ? : Tax
Choose a pill
Alain Rodermann
Managing Partner
@alroder
Questions

UJF master 2 14/10/2015